![](/accounts/bscai/images/print-logo.png)
ISCT 2023 Presidential Plenary: LA PRÉSIDENTIELLE – A DEEP DIVE INTO THE FUTURE OF IMMUNE EFFECTOR CELL THERAPIES FOR CANCER
Already registered?
Log in now.
ISCT 2023 Presidential Plenary: LA PRÉSIDENTIELLE – A DEEP DIVE INTO THE FUTURE OF IMMUNE EFFECTOR CELL THERAPIES FOR CANCER
Chairs:
- Jacques Galipeau, MD, FRCP (C), University of Wisconsin- Madison, US
Speakers:
- Bruce Levine, PhD, University of Pennsylvania, US (Recording not available)
- Anna Sureda, MD, PhD, Institut Català d’Oncologia - Hospital Duran i Reynals (Barcelona), ES (Recording and slides not available)
- Mark Lowdell, PhD, FRCPath, FRSB, InmuneBio Inc., UK
Key:
![](/images/product-status-icons/complete-small.png)
![](/images/product-status-icons/next-small.png)
![](/images/product-status-icons/disabled-small.png)
![](/images/product-status-icons/optional-small.png)
![](/images/product-status-icons/locked-small.png)
Slides: Design and Delivery of Transformational CAR T Immunotherapy Machines
Open to download resource.
Open to download resource.
Bruce Levine, PhD, University of Pennsylvania, US
Recording: Tumor-primed Memory Like-NK cells: immunological heresy translates to clinical application
Open to view video.
Open to view video.
Mark Lowdell, PhD, FRCPath, FRSB, InmuneBio Inc., UK